复方托品酰胺在远视儿童散瞳验光中的研究进展  

Research Progress of Compound Topinamide in Mydriasis Optometry in Hyperopia Children

作　　者：张雅娟[1] ZHANG Yia-juan(Tianjin Baodi District Chinese Medicine Hospital,Tianjin 301800,China)

机构地区：[1]天津市宝坻区中医医院,天津301800

出　　处：《药品评价》2020年第11期8-9,46,共3页Drug Evaluation

摘　　要：远视是影响儿童视力发育的常见因素。因儿童远视未能得到及时的检查与治疗,常造成弱视的发生。准确的散瞳验光是合理及时解决儿童远视、弱视、斜视等眼部疾病的关键。本文主要介绍了远视的病因及临床表现,分析了散瞳验光对儿童的影响与优点,阐述了复方托品酰胺在远视儿童散瞳验光中的应用效果,包括药物起效快,持续时间短,不会对儿童第二天的生活与学习产生影响。希望能为远视儿童散瞳验光的有效进行提供有效的参考意见。Hyperopia is a common factor affecting children’s visual development.Children with hyperopia can not be examined and treated,often resulting in amblyopia.Accurate mydriasis optometry is the key to solve the ocular diseases such as hyperopia,amblyopia and strabismus in children.This paper mainly introduces the etiology and clinical manifestations of hyperopia,analyzes the effects and advantages of mydriasis optometry on children,and expounds the application effect of compound topinamide in mydriasis optometry of hyperopic children,including the rapid onset and short duration of drugs,which will not affect children’s life and study the next day.It is hoped that it can provide an effective reference for far-sighted children with mydriasis optometry.

关 键 词：远视儿童 研究进展 复方托品酰胺 散瞳验光 

分 类 号：R778.12[医药卫生—眼科]